BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15180753)

  • 1. Recent advances in pathogenesis and management of hypereosinophilic syndromes.
    Roufosse F; Cogan E; Goldman M
    Allergy; 2004 Jul; 59(7):673-89. PubMed ID: 15180753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytic variant hypereosinophilic syndromes.
    Roufosse F; Cogan E; Goldman M
    Immunol Allergy Clin North Am; 2007 Aug; 27(3):389-413. PubMed ID: 17868856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypereosinophilic syndrome revisited.
    Roufosse F; Cogan E; Goldman M
    Annu Rev Med; 2003; 54():169-84. PubMed ID: 12525672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants.
    Roufosse F; Goldman M; Cogan E
    Semin Respir Crit Care Med; 2006 Apr; 27(2):158-70. PubMed ID: 16612767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypereosinophilic syndromes.
    Roufosse FE; Goldman M; Cogan E
    Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypereosinophilic syndrome and proliferative diseases.
    Ionescu MA; Wang L; Janin A
    Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical overview of hypereosinophilic syndromes.
    Sheikh J; Weller PF
    Immunol Allergy Clin North Am; 2007 Aug; 27(3):333-55. PubMed ID: 17868853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloproliferative hypereosinophilic syndrome presenting as cardiac failure and response to imatinib.
    Desai N; Morkhandikar S; Sahay R; Jijina F; Patil P
    Am J Ther; 2014; 21(2):e35-7. PubMed ID: 24603276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practical approach to hypereosinophilia].
    Roufosse F; Cogan E
    Rev Med Brux; 2008 Sep; 29(4):400-8. PubMed ID: 18949995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypereosinophilic syndrome].
    Troelsen LN; Boisen LW; Andersen O
    Ugeskr Laeger; 2005 Dec; 167(49):4663-4. PubMed ID: 16336860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of the hypereosinophilic syndromes.
    Cogan E; Roufosse F
    Expert Rev Hematol; 2012 Jun; 5(3):275-89; quiz 290. PubMed ID: 22780208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic myeloid neoplasms.
    Noel P; Mesa RA
    Curr Opin Hematol; 2013 Mar; 20(2):157-62. PubMed ID: 23385615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypereosinophilia.
    Bain BJ
    Curr Opin Hematol; 2000 Jan; 7(1):21-5. PubMed ID: 10608500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent breakthroughs in the understanding and management of chronic eosinophilic leukemia.
    Lierman E; Cools J
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1295-304. PubMed ID: 19761433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate for the treatment of hypereosinophilic syndromes.
    Antoniu SA
    Curr Opin Investig Drugs; 2006 Nov; 7(11):980-4. PubMed ID: 17117585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
    Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
    Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Idiopathic hypereosinophilic syndrome].
    Blanc AS; Blétry O
    Rev Prat; 2000 Mar; 50(6):616-21. PubMed ID: 10808317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
    Garg A; Duggal L; Aggarwal S; Jain N
    J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypereosinophilia: focus on clinical aspects].
    Cogan E
    Rev Med Brux; 1994; 15(2):55-60. PubMed ID: 8029573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glivek in the therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome].
    Nemchenko IS; Khoroshko ND; Turkina AG; Vinogradova OIu; Sokolova MA; Abakumov EM; Semenova EA; Zakharova AV; Domracheva EV
    Ter Arkh; 2004; 76(7):87-90. PubMed ID: 15379136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.